Amazon Pharmacy starts delivering $50 GLP‑1s to eligible Medicare patients, with same-day service in 3,100 cities

What happened

Amazon says it expects that same-day footprint to reach close to 4,500 communities by the end of 2026. Patients do not need a Prime membership, and pickup is available at Amazon Pharmacy kiosks in selected One Medical offices.

The medications covered are Wegovy in both injectable and tablet form, the Zepbound KwikPen, and Foundayo, Eli Lilly's orforglipron pill.

The $50 price is not Amazon's discount. It comes from the Medicare GLP-1 Bridge, a short-term demonstration run by the Centers for Medicare and Medicaid Services that started July 1, 2026 and is scheduled to end December 31, 2027. Amazon's contribution is the logistics layer: the company says it verifies eligibility, handles prior authorization, and begins enrollment on the patient's behalf once a clinician sends an electronic prescription.

CMS sets the eligibility rules, and they are specific. A person must be 18 or older, enrolled in a Medicare Part D plan, and meet clinical criteria at the time GLP-1 treatment begins: a BMI of 35 or higher; or a BMI of 30 or higher with heart failure, uncontrolled hypertension, or chronic kidney disease; or a BMI of 27 or higher with prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease.

One structural detail in the CMS documentation matters more than it sounds. Drugs supplied through the Bridge sit outside the normal Part D payment flow. The Part D deductible does not apply, but the $50 copay also does not count toward a beneficiary's true out-of-pocket total, and the low-income subsidy does not apply to it.

What it means

If you are on Medicare Part D and you meet one of those clinical profiles, the practical friction of getting a GLP-1 just dropped. Prior authorization paperwork and pharmacy stock problems are two of the most common reasons prescriptions stall, and a large mail pharmacy taking both on removes real barriers. Same-day or next-day delivery also helps with a medication people are supposed to take on a fixed schedule.

It is worth understanding what you are buying into. The $50 price is guaranteed only as long as the demonstration runs. If you start now and the program ends as scheduled at the close of 2027, you will need a plan for what comes next, because the list price of these drugs is far higher and Part D coverage of obesity medications is not settled. That is a conversation to have with your prescriber before you start, not after.

What it does not mean

This is not Medicare adding permanent coverage for obesity medications, and it is not an Amazon price cut. It is a temporary federal demonstration with a published end date, and any pharmacy participating in it charges the same $50. It does not help people on Medicare Advantage without Part D drug coverage, people on Medicaid alone, people with commercial insurance, or people with no coverage. Meeting the BMI threshold is not enough by itself unless one of the listed conditions applies at the lower thresholds. Because the copay does not count toward true out-of-pocket costs and the low-income subsidy does not apply, some beneficiaries who normally pay very little for drugs may find $50 is not a bargain for them. Same-day delivery also does not mean same-day approval; eligibility checks and prior authorization still take time. And nothing about faster delivery changes whether a GLP-1 is the right treatment for you.